PUBLISHER: Acute Market Reports | PRODUCT CODE: 1180648
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1180648
Hospital Acquired Disease Testing Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
Hospital acquired infections (HAI) or diseases, also called as nosocomial infections are acquired in healthcare in-patient settings. It is estimated that in the U.S., 9.2 out of every 100 parents acquire hospital infection. Urinary tract infection and pneumonia are the most common types of HAI, followed by bloodstream infection, and surgical site infection. These infections are caused by pathogens, among patients with compromised immunity. Patients may also develop HAIs due to sub-standard healthcare settings and negligence on the part of hospital staff. The mortality and morbidity of HAIs and the associated costs has urged caregivers for devising efficient infection control strategies. Accurate and in-time diagnosis of HAIs are vital for efficient control and management of HAI.
The global hospital acquired disease testing market report studies this market in terms of major types of HAIs. These include hospital-acquired pneumonia, urinary tract infection, bloodstream infection, surgical site infection, Methicillin-resistant Staphylococcus aureus (MRSA) and others.
Qualitative information such as drivers, challenges, and future prospects for the global hospital acquired disease testing market are included in this report. Competition assessment tools such as fractal map analysis and attractive investment proposition are presented in this study for scrutinizing competition of the global hospital acquired disease testing market. This study concludes with company profiles section that highlights information about the key companies engaged in development, manufacture and provision of hospital acquired disease testing products.
Infection Type Segmentation Investigation
Pneumonia and urinary tract infection are the most common hospital acquired infections and the largest market segments in 2015. Nosocomial pneumonia, healthcare associated pneumonia and ventilator-associated pneumonia are the chief causes of mortality and morbidity in hospital settings. Surgical site infection is the third common nosocomial infection and involves skin, muscle and subcutaneous tissue. The attributable mortality of blood stream infection is 20%, thus making this segment among the deadliest conditions and thus the most addressable.
North America is the largest market for hospital-acquired disease testing, due to multitude of hospital admissions, and the growing need for containment of rising morbidity. Stringent guidelines for infection reduction and thus culminating the risk of readmission in hospitals have urged the emerging markets to grow at a rapid CAGR during the forecast period.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Hospital Acquired Disease Testing market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Hospital Acquired Disease Testing market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Infection Type
Pneumonia
Urinary Tract Infection
Blood Stream Infection
Surgical Site Infection
MRSA
Others
Region Segment (2020-2030; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Global Impact of COVID-19 Segment (2020-2021; US$ Million )
Pre COVID-19 situation
Post COVID-19 situation
Key questions answered in this report:
What are the key micro and macro environmental factors that are impacting the growth of Hospital Acquired Disease Testing market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2030.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Hospital Acquired Disease Testing market?
Which is the largest regional market for Hospital Acquired Disease Testing market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Hospital Acquired Disease Testing market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Hospital Acquired Disease Testing market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Hospital Acquired Disease Testing Market
- 2.2. Global Hospital Acquired Disease Testing Market, By Infection Type, 2021 (US$ Million)
- 2.3. Global Hospital Acquired Disease Testing Market, By Geography, 2021 (US$ Million)
- 2.4. Attractive Investment Proposition by Geography, 2021
3. Hospital Acquired Disease Testing Market: Competitive Analysis
- 3.1. Market Positioning of Key Hospital Acquired Disease Testing Market Vendors
- 3.2. Strategies Adopted by Hospital Acquired Disease Testing Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2021 Versus 2030
4. Hospital Acquired Disease Testing Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Hospital Acquired Disease Testing Market Value, 2020 - 2030, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
5. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2021 Versus 2030
- 5.3. Market Segmentation
- 5.3.1. Pneumonia
- 5.3.2. Urinary Tract Infection
- 5.3.3. Blood Stream Infection
- 5.3.4. Surgical Site Infection
- 5.3.5. MRSA
- 5.3.6. Others
6. North America Hospital Acquired Disease Testing Market, 2020-2030, USD (Million)
- 6.1. Market Overview
- 6.2. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 6.3.Hospital Acquired Disease Testing Market: By Region, 2020-2030, USD (Million)
- 6.3.1.North America
- 6.3.1.1. U.S.
- 6.3.1.1.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 6.3.1.2. Canada
- 6.3.1.2.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 6.3.1.3. Rest of North America
- 6.3.1.3.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 6.3.1.1. U.S.
- 6.3.1.North America
7. UK and European Union Hospital Acquired Disease Testing Market, 2020-2030, USD (Million)
- 7.1. Market Overview
- 7.2. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 7.3.Hospital Acquired Disease Testing Market: By Region, 2020-2030, USD (Million)
- 7.3.1.UK and European Union
- 7.3.1.1. UK
- 7.3.1.1.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 7.3.1.2. Germany
- 7.3.1.2.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 7.3.1.3. Spain
- 7.3.1.3.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 7.3.1.4. Italy
- 7.3.1.4.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 7.3.1.5. France
- 7.3.1.5.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 7.3.1.6. Rest of Europe
- 7.3.1.6.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 7.3.1.1. UK
- 7.3.1.UK and European Union
8. Asia Pacific Hospital Acquired Disease Testing Market, 2020-2030, USD (Million)
- 8.1. Market Overview
- 8.2. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 8.3.Hospital Acquired Disease Testing Market: By Region, 2020-2030, USD (Million)
- 8.3.1.Asia Pacific
- 8.3.1.1. China
- 8.3.1.1.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 8.3.1.2. Japan
- 8.3.1.2.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 8.3.1.3. India
- 8.3.1.3.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 8.3.1.4. Australia
- 8.3.1.4.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 8.3.1.5. South Korea
- 8.3.1.5.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 8.3.1.6. Rest of Asia Pacific
- 8.3.1.6.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 8.3.1.1. China
- 8.3.1.Asia Pacific
9. Latin America Hospital Acquired Disease Testing Market, 2020-2030, USD (Million)
- 9.1. Market Overview
- 9.2. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 9.3.Hospital Acquired Disease Testing Market: By Region, 2020-2030, USD (Million)
- 9.3.1.Latin America
- 9.3.1.1. Brazil
- 9.3.1.1.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 9.3.1.2. Mexico
- 9.3.1.2.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 9.3.1.3. Rest of Latin America
- 9.3.1.3.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 9.3.1.1. Brazil
- 9.3.1.Latin America
10. Middle East and Africa Hospital Acquired Disease Testing Market, 2020-2030, USD (Million)
- 10.1. Market Overview
- 10.2. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 10.3.Hospital Acquired Disease Testing Market: By Region, 2020-2030, USD (Million)
- 10.3.1.Middle East and Africa
- 10.3.1.1. GCC
- 10.3.1.1.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 10.3.1.2. Africa
- 10.3.1.2.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 10.3.1.3. Rest of Middle East and Africa
- 10.3.1.3.1. Hospital Acquired Disease Testing Market: By Infection Type, 2020-2030, USD (Million)
- 10.3.1.1. GCC
- 10.3.1.Middle East and Africa
11. Company Profile
- 11.1. Becton Dickinson
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Portfolio
- 11.1.4. Strategic Initiatives
- 11.2. bioMerieux
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Portfolio
- 11.2.4. Strategic Initiatives
- 11.3. Cantel
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Portfolio
- 11.3.4. Strategic Initiatives
- 11.4. Cepheid
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Portfolio
- 11.4.4. Strategic Initiatives
- 11.5. Diatherix
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Portfolio
- 11.5.4. Strategic Initiatives
- 11.6. Qiagen
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Portfolio
- 11.6.4. Strategic Initiatives
- 11.7. Nordion
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Portfolio
- 11.7.4. Strategic Initiatives
- 11.8. Roche
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Portfolio
- 11.8.4. Strategic Initiatives
- 11.9. Others
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Portfolio
- 11.9.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 2 North America Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 3 U.S. Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 4 Canada Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 5 Rest of North America Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 6 UK and European Union Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 7 UK Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 8 Germany Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 9 Spain Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 10 Italy Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 11 France Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 12 Rest of Europe Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 13 Asia Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 14 China Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 15 Japan Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 16 India Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 17 Australia Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 18 South Korea Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 19 Latin America Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 20 Brazil Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 21 Mexico Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 22 Rest of Latin America Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 23 Middle East and Africa Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 24 GCC Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 25 Africa Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
- TABLE 26 Rest of Middle East and Africa Hospital Acquired Disease Testing Market By Infection Type, 2020-2030, USD (Million)
List of Figures
- FIG. 1 Global Hospital Acquired Disease Testing Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Hospital Acquired Disease Testing Market: Quality Assurance
- FIG. 5 Global Hospital Acquired Disease Testing Market, By Infection Type, 2021
- FIG. 6 Global Hospital Acquired Disease Testing Market, By Geography, 2021
- FIG. 7 Market Geographical Opportunity Matrix - Global Hospital Acquired Disease Testing Market, 2021
- FIG. 8 Market Positioning of Key Hospital Acquired Disease Testing Market Players, 2021
- FIG. 9 Global Hospital Acquired Disease Testing Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
- FIG. 10 Global Hospital Acquired Disease Testing Market, By Infection Type, 2021 Vs 2030, %
- FIG. 11 U.S. Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 12 Canada Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 13 Rest of North America Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 14 UK Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 15 Germany Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 16 Spain Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 17 Italy Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 18 France Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 19 Rest of Europe Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 20 China Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 21 Japan Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 22 India Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 23 Australia Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 24 South Korea Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 25 Rest of Asia Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 26 Brazil Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 27 Mexico Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 28 Rest of Latin America Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 29 GCC Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 30 Africa Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
- FIG. 31 Rest of Middle East and Africa Hospital Acquired Disease Testing Market (US$ Million), 2020 - 2030
